World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
44571
World Ranking
10293
National Ranking
5295

Gary R. Lichtenstein publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gary R. Lichtenstein sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 889 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Gary R. Lichtenstein D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gary R. Lichtenstein sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Gary R. Lichtenstein is affiliated with the University of Pennsylvania in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant work in subfields including Genetics, Epidemiology, Surgery, Immunology, and Oncology.

The scientist's work extensively covers topics related to Inflammatory Bowel Disease, Microscopic Colitis, Immunodeficiency and Autoimmune Disorders, Eosinophilic Esophagitis, Helicobacter pylori-related gastroenterology studies, Diagnosis and treatment of tuberculosis, and Diverticular Disease and Complications.

Frequent publication venues for Gary R. Lichtenstein include Gastroenterology, The American Journal of Gastroenterology, Inflammatory Bowel Diseases, Journal of Crohn's and Colitis, and Digestive Diseases and Sciences.

Frequent co-authors collaborating with Lichtenstein are:

  • Abhik Bhattacharya (15 works)
  • Mark T. Osterman (14 works)
  • Bhavana Bhagya Rao (11 works)
  • James D. Lewis (10 works)
  • Daniel Travis (8 works)

Recent papers authored or co-authored by Gary R. Lichtenstein include:

  • ACG Clinical Guideline: Management of Crohn's Disease in Adults, 2025, The American Journal of Gastroenterology
  • Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan® Administrative Claims Database With Tofacitinib Trial Data, 2020, Inflammatory Bowel Diseases
  • Medical, Political, and Economic Considerations for the Use of MAC for Endoscopic Sedation: Big Price, Little Justification?, 2020, Digestive Diseases and Sciences
  • A Multimodal Intervention Using Nonopioid Analgesics Is Associated With Reduced Intravenous Opioid Exposure Among Hospitalized Patients With Inflammatory Bowel Diseases, 2020, The American Journal of Gastroenterology
  • Care of immunocompromised patients with head and neck cancer during the COVID-19 pandemic: Two challenging and informative clinical cases, 2020, Head & Neck

Best Publications

  • Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

    Stephen B Hanauer;Brian G Feagan;Gary R Lichtenstein;Lloyd F Mayer

  • Infliximab for induction and maintenance therapy for ulcerative colitis.

    Paul Rutgeerts;William J Sandborn;Brian G Feagan;Walter Reinisch

  • Management of Crohn's Disease in Adults

    Gary R Lichtenstein;Stephen B Hanauer;Stephen B Hanauer;Stephen B Hanauer;William J Sandborn;William J Sandborn;William J Sandborn

  • Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease.

    Paul Rutgeerts;Brian G. Feagan;Gary R. Lichtenstein;Lloyd F. Mayer

  • ACG Clinical Guideline: Management of Crohn’s Disease in Adults

    Gary R Lichtenstein;Edward V Loftus;Kim L Isaacs;Miguel D Regueiro

  • Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry

    Gary R. Lichtenstein;Brian G. Feagan;Russell D. Cohen;Bruce A. Salzberg

  • Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

    Jean Frédéric Colombel;Paul Rutgeerts;Walter Reinisch;Dirk Esser

  • Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis

    James D. Lewis;Shaokun Chuai;Lisa Nessel;Gary R. Lichtenstein

  • Serious Infection and Mortality in Patients With Crohn ' s Disease: More Than 5 Years of Follow-Up in the TREAT ™ Registry

    Gary R Lichtenstein;Brian G Feagan;Russell D Cohen;Bruce A Salzberg

  • Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn’s disease

    Gary R. Lichtenstein;Songkai Yan;Mohan Bala;Marion Blank

  • Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease

    Paul Rutgeerts;Robert H. Diamond;Mohan Bala;Allan Olson

  • Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

    Simon P L Travis;Dan Schnell;Piotr Krzeski;Maria T Abreu

  • American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease

    Gary R. Lichtenstein;Maria T. Abreu;Russell Cohen;William Tremaine

  • Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab

    William J. Sandborn;Paul Rutgeerts;Brian G. Feagan;Walter Reinisch

  • Outcome of Pregnancy in Women Receiving Infliximab for the Treatment of Crohn's Disease and Rheumatoid Arthritis

    Jeffry A Katz;Christian Antoni;Gregory F Keenan;Deirdre E Smith

  • A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease.

    David S. Kotlyar;Mark T. Osterman;Robert H. Diamond;David Porter

  • ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.

    Francis A Farraye;Gil Y Melmed;Gary R Lichtenstein;Sunanda V Kane

  • Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis.

    Mark T. Osterman;Rabi Kundu;Gary R. Lichtenstein;James D. Lewis

  • Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity

    Simon P.L. Travis;Dan Schnell;Piotr Krzeski;Maria T. Abreu

  • Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.

    David S. Kotlyar;David S. Kotlyar;James D. Lewis;Laurent Beaugerie;Ann Tierney

Frequent Co-Authors

James D. Lewis
James D. Lewis University of Pennsylvania
William J. Sandborn
William J. Sandborn University of California, San Diego
Brian G. Feagan
Brian G. Feagan University of Western Ontario
Stephen B. Hanauer
Stephen B. Hanauer Northwestern University
Edward V. Loftus
Edward V. Loftus Mayo Clinic
Stefan Schreiber
Stefan Schreiber Kiel University
Michael A. Kamm
Michael A. Kamm University of Melbourne
Jean-Frederic Colombel
Jean-Frederic Colombel Icahn School of Medicine at Mount Sinai
Bruce E. Sands
Bruce E. Sands Icahn School of Medicine at Mount Sinai
Walter Reinisch
Walter Reinisch Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While studying Medicine in the USA often means pursuing a traditional medical degree, there are alternative online pathways for those interested in the healthcare field. For students wanting to enter the workforce quickly, fast track lpn programs provide an accelerated route to become a Licensed Practical Nurse.

For nurses who want to specialize in mental health, online pmhnp programs offer flexible studies that lead to advanced roles as Psychiatric Mental Health Nurse Practitioners. These programs are ideal for registered nurses seeking in-depth expertise and job growth.

If healthcare leadership and management appeal to you, pursuing a Master of Healthcare Administration (MHA) can unlock administrative and executive opportunities. You can explore the best online mha programs for comprehensive, accredited studies. Concerned about finances? Check out the cheapest online mha options to maximize the value of your investment.

Best Scientists Citing Gary R. Lichtenstein

Trending Scientists

Recently Published Articles